Current practices

Many medical associations recommend screening for celiac disease (CD) in at-risk groups. There is a lack of consensus among guidelines on who to screen and how, particularly in patients with type 1 diabetes mellitus (T1DM). The goal of the present survey is to evaluate current practices and the factors influencing the screening of CD in asymptomatic (having no digestive nor extra-digestive symptoms) patients with T1DM across North America and Europe.

Question Title

* 2. Do you inform your asymptomatic patients with T1DM that they are at increased risk of CD?

Question Title

* 3. Are you screening for CD in your asymptomatic patients with T1DM?

Question Title

* 4. Indicate the frequency by which you employ the following CD screening tests, when screening in asymptomatic patients with T1DM:

  Always Frequently Sometimes Never
Search for HLA-DQ2 and HLA-DQ8
Anti-transglutaminase antibodies
Anti-gliadin antibodies
Anti-endomysial antibodies
Total IgA level
Repeat antibody titer when the first screen is positive

Question Title

* 5. What is your preferred next step following a positive screen for CD in an asymptomatic patients with T1DM? (Select the answer most typical of your usual practice)

Question Title

* 6. What would be the consequences of not treating the CD of an asymptomatic patient?(Select as many answers as needed, or tick ''none of these consequences'')

T